Mersana Therapeutics Stock Price on September 23, 2024
| MRSN Stock | USD 2.19 0.02 0.92% |
Below is the normalized historical share price chart for Mersana Therapeutics extending back to June 28, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Mersana Therapeutics stands at 2.19, as last reported on the 28th of November, with the highest price reaching 2.23 and the lowest price hitting 2.11 during the day.
If you're considering investing in Mersana Stock, it is important to understand the factors that can impact its price. Mersana Therapeutics appears to be dangerous, given 3 months investment horizon. Mersana Therapeutics has Sharpe Ratio of 0.11, which conveys that the firm had a 0.11% return per unit of risk over the last 3 months. By analyzing Mersana Therapeutics' technical indicators, you can evaluate if the expected return of 0.72% is justified by implied risk. Please exercise Mersana Therapeutics' Risk Adjusted Performance of 0.0928, mean deviation of 4.85, and Downside Deviation of 5.85 to check out if our risk estimates are consistent with your expectations.
At this time, Mersana Therapeutics' Total Stockholder Equity is very stable compared to the past year. As of the 28th of November 2024, Common Stock Shares Outstanding is likely to grow to about 121.9 M, while Common Stock Total Equity is likely to drop 4,243. . At this time, Mersana Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 28th of November 2024, Price To Book Ratio is likely to grow to 7.66, while Price To Sales Ratio is likely to drop 6.94. Mersana Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of June 2017 | 200 Day MA 2.6674 | 50 Day MA 2.073 | Beta 1.475 |
Mersana |
Sharpe Ratio = 0.1085
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MRSN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.68 actual daily | 59 59% of assets are less volatile |
Expected Return
| 0.72 actual daily | 14 86% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Mersana Therapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mersana Therapeutics by adding it to a well-diversified portfolio.
Price Book 257.9 | Enterprise Value Ebitda (2.20) | Price Sales 7.7658 | Shares Float 71.3 M | Wall Street Target Price 6.5 |
Related Headline
Amylyx Pharmaceuticals Headline on 23rd of September 2024
Disposition of 1857 shares by Joshua Cohen of Amylyx Pharmac... by Joshua Cohen
Filed transaction by Amylyx Pharmaceuticals Director, Officer: Co-chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Mersana Therapeutics Valuation on September 23, 2024
It is possible to determine the worth of Mersana Therapeutics on a given historical date. On September 23, 2024 Mersana was worth 2.16 at the beginning of the trading date compared to the closed value of 1.95. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Mersana Therapeutics stock. Still, in general, we apply an absolute valuation method to find Mersana Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Mersana Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Mersana Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.18 | 2.22 | 2.13 | 2.16 | 1,343,629 | |
09/23/2024 | 2.16 | 2.16 | 1.91 | 1.95 | 661,980 |
| 1.95 | 1.97 | 1.86 | 1.89 | 399,778 |
| Backtest Mersana Therapeutics | | | Mersana Therapeutics History | | | Mersana Therapeutics Valuation | Previous | Next |
Mersana Therapeutics Trading Date Momentum on September 23, 2024
| On September 24 2024 Mersana Therapeutics was traded for 1.89 at the closing time. The top price for the day was 1.97 and the lowest listed price was 1.86 . The trading volume for the day was 399.8 K. The trading history from September 24, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 3.08% . The trading delta at closing time against the current closing price is 3.08% . |
Mersana Therapeutics Fundamentals Correlations and Trends
By evaluating Mersana Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Mersana Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Mersana financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Mersana Therapeutics Stock history
Mersana Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Mersana is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Mersana Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Mersana Therapeutics stock prices may prove useful in developing a viable investing in Mersana Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 116.1 M | 121.9 M | |
| Net Loss | -183.8 M | -174.6 M |
Mersana Therapeutics Quarterly Net Working Capital |
|
Mersana Therapeutics Stock Technical Analysis
Mersana Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Mersana Therapeutics Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Mersana Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Mersana Therapeutics November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Mersana Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mersana Therapeutics shares will generate the highest return on investment. By undertsting and applying Mersana Therapeutics stock market strength indicators, traders can identify Mersana Therapeutics entry and exit signals to maximize returns
Mersana Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Mersana Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Mersana Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Mersana to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0928 | |||
| Jensen Alpha | 0.2438 | |||
| Total Risk Alpha | (0.28) | |||
| Sortino Ratio | 0.1025 | |||
| Treynor Ratio | 0.1751 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mersana Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Mersana Stock, please use our How to Invest in Mersana Therapeutics guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mersana Therapeutics. If investors know Mersana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mersana Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.60) | Revenue Per Share 0.286 | Quarterly Revenue Growth 0.637 | Return On Assets (0.26) | Return On Equity (2.13) |
The market value of Mersana Therapeutics is measured differently than its book value, which is the value of Mersana that is recorded on the company's balance sheet. Investors also form their own opinion of Mersana Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Mersana Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mersana Therapeutics' market value can be influenced by many factors that don't directly affect Mersana Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mersana Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mersana Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mersana Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.